Terms: = Ovarian cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Diagnosis
230 results:
1. Neuroendocrine neoplasms of the ovary: a review of 63 cases.
Flores Legarreta A; Saab R; Gonzales NR; Chisholm GB; Westin SN; Hillman RT; Frumovitz M
Int J Gynecol Cancer; 2024 Apr; 34(4):566-573. PubMed ID: 38290783
[TBL] [Abstract] [Full Text] [Related]
2. Reduced healthcare access contributes to delay of care in endometrial cancer.
Fife AJ; Najor AJ; Aspir TB; Haines KE; Vilardo NA; Isani SS; Cowan M; Gressel GM; Ye KQ; Nevadunsky NS; Kuo DY; Lin KY
Gynecol Oncol; 2024 Mar; 182():115-120. PubMed ID: 38262233
[TBL] [Abstract] [Full Text] [Related]
3. Rationale and methodologic Approach for Assessing ovarian cancer Treatment and Gynecologic Oncologist Involvement in the Midwest Region of the United States.
Ng D; Ross W; Traverso-Ortiz M; Rim SH; Wike JM; Moore AR;
J Registry Manag; 2023; 50(3):85-91. PubMed ID: 37941740
[TBL] [Abstract] [Full Text] [Related]
4. "Floating ball sign" in the diagnostic imaging of mature ovarian teratomas in children.
Szymon O; Kiszka-Wiłkojć A; Fryczek M; Taczanowska-Niemczuk A; Wyrobek Ł; Górecki W
Pediatr Surg Int; 2023 Jun; 39(1):215. PubMed ID: 37326782
[TBL] [Abstract] [Full Text] [Related]
5. HYPERPLASIA OF THE FEMALE REPRODUCTIVE ORGANS IN UKRAINE.
Salmanov AG; Artyomenko V; Hladenko SY; Koctjuk IM; Marchenko AO; Tolstanova GO; Korniyenko SM
Wiad Lek; 2023; 76(3):467-473. PubMed ID: 37057766
[TBL] [Abstract] [Full Text] [Related]
6. The Utility of Fallopian Tube Cytology in the Early Detection of Extrauterine Serous Gynecological Malignancies: A Narrative Literature Review.
Psomiadou V; Lekka S; Panoskaltsis T; Tsouma H; Novkovic N; Trihia HJ; Tzaida O; Korfias D; Giannakas P; Iavazzo C; Papadimitriou C; Vlahos N; Vorgias G
Acta Cytol; 2023; 67(5):519-527. PubMed ID: 37044076
[TBL] [Abstract] [Full Text] [Related]
7. Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.
Wimberger P; Pfisterer J; du Bois A; Hilpert F; Kerkmann M; Sehouli J; Mahner S; de Gregorio N; Hanker L; Heitz F; Marmé F; Woelber L; Holtmann L; Elser G; Harter P;
Int J Gynecol Cancer; 2023 Jul; 33(7):1083-1089. PubMed ID: 37001891
[TBL] [Abstract] [Full Text] [Related]
8. Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.
Acevedo F; Walbaum B; Camus M; Manzor M; Muñiz S; Medina L; Petric M; Reyes P; Domínguez F; Puschel K; Merino T; Bravo ML; Pinto MP; Ibáñez C; Hughes K; Sánchez C
Breast Cancer Res Treat; 2023 Jun; 199(2):363-370. PubMed ID: 36988750
[TBL] [Abstract] [Full Text] [Related]
9. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
Terp SK; Stoico MP; Dybkær K; Pedersen IS
Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
[TBL] [Abstract] [Full Text] [Related]
10. cancer-associated spinal cord infarction: A systematic review and analysis of survival predictors.
Puente-Hernandez M; Rivero-de-Aguilar A; Varela-Lema L
J Neurol Sci; 2023 Mar; 446():120580. PubMed ID: 36764185
[TBL] [Abstract] [Full Text] [Related]
11. Exercise adherence in a randomized controlled trial of exercise on quality of life in ovarian cancer survivors.
Cao A; Cartmel B; Li FY; Gottlieb LT; Harrigan M; Ligibel JA; Gogoi R; Schwartz PE; Irwin ML; Ferrucci LM
J Cancer Surviv; 2023 Apr; 17(2):535-543. PubMed ID: 36550261
[TBL] [Abstract] [Full Text] [Related]
12. Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study.
Taji T; Odan N; Kataoka Y; Ikeda M; Yamaguchi A; Suzuki E; Suwa H
Breast Cancer; 2023 Mar; 30(2):309-314. PubMed ID: 36547869
[TBL] [Abstract] [Full Text] [Related]
13. External Validation of the ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International ovarian Tumor Analysis 2-Step Strategy to Stratify ovarian Tumors Into O-RADS Risk Groups.
Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
[TBL] [Abstract] [Full Text] [Related]
14. Systematic mapping review of guidelines for
Hughes BN; Jorgensen KA; Cummings S; Morah D; Krause K; Rauh-Hain JA; Herzog TJ
Int J Gynecol Cancer; 2023 Feb; 33(2):250-256. PubMed ID: 36368709
[TBL] [Abstract] [Full Text] [Related]
15. Outcomes after assisted reproductive technology in women with cancer: a systematic review and meta-analysis.
Meernik C; Poole C; Engel SM; Rauh-Hain JA; Luke B; Nichols HB
Hum Reprod; 2023 Jan; 38(1):30-45. PubMed ID: 36342891
[TBL] [Abstract] [Full Text] [Related]
16. Identification and prioritization of tumour-associated antigens for immunotherapeutic and diagnostic capacity in epithelial ovarian cancer: a systematic literature review.
Wiseman L; Cinti N; Guinn BA
Carcinogenesis; 2022 Dec; 43(11):1015-1029. PubMed ID: 36318800
[TBL] [Abstract] [Full Text] [Related]
17. Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors.
Conley CC; Rivera Rivera JN; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Ricker C; Quinn GP; Soliman H; Vadaparampil ST
Transl Behav Med; 2022 Oct; 12(9):900-908. PubMed ID: 36205471
[TBL] [Abstract] [Full Text] [Related]
18. [A case of CA19-9-producing esophagogastric junction cancer with ovarian juvenile granulosa cell tumor and rectal cancer].
Kawada M; Takaoka M; Fujiwara H; Kawamoto H; Urakami A; Yamatsuji T
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(8):750-760. PubMed ID: 35944993
[TBL] [Abstract] [Full Text] [Related]
19. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial ovarian cancer.
Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
[TBL] [Abstract] [Full Text] [Related]
20. PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina.
Gonzalez A; Del Greco F; Vargas-Roig L; Brun B; Tabares G; Mampel A; Montes C; Martin C; Lopez M; Rossi N; Bruno L; Ponce C; Quaglio P; Yanzi A; Acevedo S; Lugo L; Lopez Breccia P; Avila S; Sisterna S; Del Castillo MS; Vazquez M; Nuñez LM
Breast Cancer Res Treat; 2022 Jul; 194(2):403-412. PubMed ID: 35610400
[TBL] [Abstract] [Full Text] [Related]
[Next]
